Recombinant Protein Drug R D and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Recombinant Protein Drug R & D Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Drug R & D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Protein Drug R & D Overall Market Size
2.1 Global Recombinant Protein Drug R & D Market Size: 2022 VS 2030
2.2 Global Recombinant Protein Drug R & D Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Protein Drug R & D Players in Global Market
3.2 Top Global Recombinant Protein Drug R & D Companies Ranked by Revenue
3.3 Global Recombinant Protein Drug R & D Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Protein Drug R & D Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Protein Drug R & D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Protein Drug R & D Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Protein Drug R & D Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Protein Drug R & D Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Drug R & D Market Size Markets, 2022 & 2030
4.1.2 Peptide Hormones
4.1.3 Hematopoietic Factor
4.1.4 Cytokines
4.1.5 Plasma Protein Factor
4.1.6 Recombinase
4.1.7 Fusion Protein
4.1.8 Other
4.2 By Type - Global Recombinant Protein Drug R & D Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Drug R & D Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Protein Drug R & D Revenue, 2024-2030
4.2.3 By Type - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Drug R & D Market Size, 2022 & 2030
5.1.2 Diabetes
5.1.3 Dwarfism
5.1.4 Hemophilia
5.1.5 Heart Disease
5.1.6 Cancer
5.1.7 Other
5.2 By Application - Global Recombinant Protein Drug R & D Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Drug R & D Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Protein Drug R & D Revenue, 2024-2030
5.2.3 By Application - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Protein Drug R & D Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Protein Drug R & D Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Drug R & D Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Protein Drug R & D Revenue, 2024-2030
6.2.3 By Region - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Recombinant Protein Drug R & D Revenue, 2018-2030
6.3.2 US Recombinant Protein Drug R & D Market Size, 2018-2030
6.3.3 Canada Recombinant Protein Drug R & D Market Size, 2018-2030
6.3.4 Mexico Recombinant Protein Drug R & D Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Recombinant Protein Drug R & D Revenue, 2018-2030
6.4.2 Germany Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.3 France Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.4 U.K. Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.5 Italy Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.6 Russia Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.7 Nordic Countries Recombinant Protein Drug R & D Market Size, 2018-2030
6.4.8 Benelux Recombinant Protein Drug R & D Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Recombinant Protein Drug R & D Revenue, 2018-2030
6.5.2 China Recombinant Protein Drug R & D Market Size, 2018-2030
6.5.3 Japan Recombinant Protein Drug R & D Market Size, 2018-2030
6.5.4 South Korea Recombinant Protein Drug R & D Market Size, 2018-2030
6.5.5 Southeast Asia Recombinant Protein Drug R & D Market Size, 2018-2030
6.5.6 India Recombinant Protein Drug R & D Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Recombinant Protein Drug R & D Revenue, 2018-2030
6.6.2 Brazil Recombinant Protein Drug R & D Market Size, 2018-2030
6.6.3 Argentina Recombinant Protein Drug R & D Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Protein Drug R & D Revenue, 2018-2030
6.7.2 Turkey Recombinant Protein Drug R & D Market Size, 2018-2030
6.7.3 Israel Recombinant Protein Drug R & D Market Size, 2018-2030
6.7.4 Saudi Arabia Recombinant Protein Drug R & D Market Size, 2018-2030
6.7.5 UAE Recombinant Protein Drug R & D Market Size, 2018-2030
7 Recombinant Protein Drug R & D Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Recombinant Protein Drug R & D Major Product Offerings
7.1.4 Eli Lilly Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Recombinant Protein Drug R & D Major Product Offerings
7.2.4 Novo Nordisk Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.2.5 Novo Nordisk Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Recombinant Protein Drug R & D Major Product Offerings
7.3.4 Amgen Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Recombinant Protein Drug R & D Major Product Offerings
7.4.4 Merck Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Recombinant Protein Drug R & D Major Product Offerings
7.5.4 Sanofi Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Recombinant Protein Drug R & D Major Product Offerings
7.6.4 Pfizer Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Recombinant Protein Drug R & D Major Product Offerings
7.7.4 Roche Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Gensci
7.8.1 Gensci Company Summary
7.8.2 Gensci Business Overview
7.8.3 Gensci Recombinant Protein Drug R & D Major Product Offerings
7.8.4 Gensci Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.8.5 Gensci Key News & Latest Developments
7.9 Ankebio
7.9.1 Ankebio Company Summary
7.9.2 Ankebio Business Overview
7.9.3 Ankebio Recombinant Protein Drug R & D Major Product Offerings
7.9.4 Ankebio Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.9.5 Ankebio Key News & Latest Developments
7.10 United Cell
7.10.1 United Cell Company Summary
7.10.2 United Cell Business Overview
7.10.3 United Cell Recombinant Protein Drug R & D Major Product Offerings
7.10.4 United Cell Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.10.5 United Cell Key News & Latest Developments
7.11 Sinobioway Hygene
7.11.1 Sinobioway Hygene Company Summary
7.11.2 Sinobioway Hygene Business Overview
7.11.3 Sinobioway Hygene Recombinant Protein Drug R & D Major Product Offerings
7.11.4 Sinobioway Hygene Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.11.5 Sinobioway Hygene Key News & Latest Developments
7.12 Kexing
7.12.1 Kexing Company Summary
7.12.2 Kexing Business Overview
7.12.3 Kexing Recombinant Protein Drug R & D Major Product Offerings
7.12.4 Kexing Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.12.5 Kexing Key News & Latest Developments
7.13 Dongbao
7.13.1 Dongbao Company Summary
7.13.2 Dongbao Business Overview
7.13.3 Dongbao Recombinant Protein Drug R & D Major Product Offerings
7.13.4 Dongbao Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.13.5 Dongbao Key News & Latest Developments
7.14 3sbio
7.14.1 3sbio Company Summary
7.14.2 3sbio Business Overview
7.14.3 3sbio Recombinant Protein Drug R & D Major Product Offerings
7.14.4 3sbio Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.14.5 3sbio Key News & Latest Developments
7.15 Gan&Lee
7.15.1 Gan&Lee Company Summary
7.15.2 Gan&Lee Business Overview
7.15.3 Gan&Lee Recombinant Protein Drug R & D Major Product Offerings
7.15.4 Gan&Lee Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.15.5 Gan&Lee Key News & Latest Developments
7.16 Hengrui
7.16.1 Hengrui Company Summary
7.16.2 Hengrui Business Overview
7.16.3 Hengrui Recombinant Protein Drug R & D Major Product Offerings
7.16.4 Hengrui Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
7.16.5 Hengrui Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Recombinant Protein Drug R & D Market Opportunities & Trends in Global Market
Table 2. Recombinant Protein Drug R & D Market Drivers in Global Market
Table 3. Recombinant Protein Drug R & D Market Restraints in Global Market
Table 4. Key Players of Recombinant Protein Drug R & D in Global Market
Table 5. Top Recombinant Protein Drug R & D Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Protein Drug R & D Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Protein Drug R & D Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Protein Drug R & D Product Type
Table 9. List of Global Tier 1 Recombinant Protein Drug R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Drug R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Protein Drug R & D Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Recombinant Protein Drug R & D Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Protein Drug R & D Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Recombinant Protein Drug R & D Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Recombinant Protein Drug R & D Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Protein Drug R & D Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Recombinant Protein Drug R & D Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Recombinant Protein Drug R & D Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Protein Drug R & D Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Protein Drug R & D Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Protein Drug R & D Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Protein Drug R & D Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Protein Drug R & D Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Protein Drug R & D Revenue, (US$, Mn), 2024-2030
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Recombinant Protein Drug R & D Product Offerings
Table 32. Eli Lilly Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Novo Nordisk Company Summary
Table 35. Novo Nordisk Recombinant Protein Drug R & D Product Offerings
Table 36. Novo Nordisk Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 37. Novo Nordisk Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Recombinant Protein Drug R & D Product Offerings
Table 40. Amgen Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Recombinant Protein Drug R & D Product Offerings
Table 44. Merck Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Recombinant Protein Drug R & D Product Offerings
Table 48. Sanofi Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Recombinant Protein Drug R & D Product Offerings
Table 52. Pfizer Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Recombinant Protein Drug R & D Product Offerings
Table 56. Roche Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Gensci Company Summary
Table 59. Gensci Recombinant Protein Drug R & D Product Offerings
Table 60. Gensci Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 61. Gensci Key News & Latest Developments
Table 62. Ankebio Company Summary
Table 63. Ankebio Recombinant Protein Drug R & D Product Offerings
Table 64. Ankebio Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 65. Ankebio Key News & Latest Developments
Table 66. United Cell Company Summary
Table 67. United Cell Recombinant Protein Drug R & D Product Offerings
Table 68. United Cell Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 69. United Cell Key News & Latest Developments
Table 70. Sinobioway Hygene Company Summary
Table 71. Sinobioway Hygene Recombinant Protein Drug R & D Product Offerings
Table 72. Sinobioway Hygene Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 73. Sinobioway Hygene Key News & Latest Developments
Table 74. Kexing Company Summary
Table 75. Kexing Recombinant Protein Drug R & D Product Offerings
Table 76. Kexing Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 77. Kexing Key News & Latest Developments
Table 78. Dongbao Company Summary
Table 79. Dongbao Recombinant Protein Drug R & D Product Offerings
Table 80. Dongbao Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 81. Dongbao Key News & Latest Developments
Table 82. 3sbio Company Summary
Table 83. 3sbio Recombinant Protein Drug R & D Product Offerings
Table 84. 3sbio Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 85. 3sbio Key News & Latest Developments
Table 86. Gan&Lee Company Summary
Table 87. Gan&Lee Recombinant Protein Drug R & D Product Offerings
Table 88. Gan&Lee Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 89. Gan&Lee Key News & Latest Developments
Table 90. Hengrui Company Summary
Table 91. Hengrui Recombinant Protein Drug R & D Product Offerings
Table 92. Hengrui Recombinant Protein Drug R & D Revenue (US$, Mn) & (2018-2023)
Table 93. Hengrui Key News & Latest Developments
List of Figures
Figure 1. Recombinant Protein Drug R & D Segment by Type in 2022
Figure 2. Recombinant Protein Drug R & D Segment by Application in 2022
Figure 3. Global Recombinant Protein Drug R & D Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Drug R & D Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Protein Drug R & D Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Protein Drug R & D Revenue in 2022
Figure 8. By Type - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 9. By Application - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 10. By Type - Global Recombinant Protein Drug R & D Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 12. By Application - Global Recombinant Protein Drug R & D Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 14. By Region - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 15. By Country - North America Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 16. US Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 20. Germany Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 21. France Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 28. China Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 32. India Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 34. Brazil Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Recombinant Protein Drug R & D Revenue Market Share, 2018-2030
Figure 37. Turkey Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Recombinant Protein Drug R & D Revenue, (US$, Mn), 2018-2030
Figure 41. Eli Lilly Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novo Nordisk Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gensci Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ankebio Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. United Cell Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sinobioway Hygene Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Kexing Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Dongbao Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. 3sbio Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Gan&Lee Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Hengrui Recombinant Protein Drug R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)